Pediculosis Clinical Trial
Official title:
Phase II, Multi-Center, Open-Label, Safety and Tolerance Study of a Novel Malathion Formulation in Infants and Toddlers With Pediculosis Capitis
In a previous phase II study, the safety and efficacy of a novel formulation of malathion
0.5% was evaluated in patients 2 years of age and older. Based on the results of that study,
this formulation is currently in a phase III study for that population.
The current study will use blood markers and clinical evaluations to determine the safety
and tolerability of this formulation when used in children 6-24 months of age.
n/a
Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01660321 -
Pharmacokinetic (PK) and Tolerance Study of Natroba Topical Suspension in Pediatrics With an Active Head Lice Infestation
|
Phase 4 | |
| Completed |
NCT00545753 -
Safety and Efficacy Study of NatrOVA Creme Rinse - 1% and NIX Creme Rinse in Subjects 6 Months or Older With Head Lice
|
Phase 3 | |
| Completed |
NCT00381082 -
A Randomised, Assessor-Blind, Comparative Efficacy Clinical Trial of 3 Pediculicides.
|
Phase 2/Phase 3 | |
| Terminated |
NCT02499549 -
Two Treatment Regimens of Cocamide DEA Lotion for Head Lice
|
Phase 2/Phase 3 | |
| Completed |
NCT05643820 -
Comparison of Oral Ivermectin and Permethrin 5% Lotion in Treatment of Pediculosis Capitis
|
Phase 1 | |
| Completed |
NCT00731718 -
Control of Head Lice Infestations in Children and Adults
|
N/A | |
| Not yet recruiting |
NCT01966965 -
Efficacy and Safety Study for PIOLIN® Shampoo
|
Phase 3 | |
| Completed |
NCT00927407 -
Pharmacokinetics of Malathion Gel 0.5% and Malathion 0.5% Lotion (Ovide) in Patients With Head Lice
|
Phase 1 | |
| Completed |
NCT01518699 -
Study to Evaluate the Effect of Ha44 Gel on the Electrocardiogram in Healthy Volunteers
|
Phase 1 | |
| Completed |
NCT00207753 -
Effectiveness of Combined Albendazole and Ivermectin Treatment for Intestinal Worm Infections
|
N/A | |
| Completed |
NCT00963508 -
Efficacy, Safety and Tolerability of a Novel Malathion Formulation in Patients 2 Years and Older With Head Lice
|
Phase 3 | |
| Completed |
NCT00927472 -
Efficacy, Safety and Tolerability of a Novel Malathion Formulation in Patients 2 Years and Older With Head Lice
|
Phase 3 | |
| Completed |
NCT01336647 -
An Efficacy and Safety Study of Ha44 Gel Administered Topically for the Treatment of Head Lice Infestation
|
Phase 2 |